BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18003925)

  • 1. Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism.
    Mosconi L; Brys M; Switalski R; Mistur R; Glodzik L; Pirraglia E; Tsui W; De Santi S; de Leon MJ
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):19067-72. PubMed ID: 18003925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease.
    Mosconi L; Mistur R; Switalski R; Brys M; Glodzik L; Rich K; Pirraglia E; Tsui W; De Santi S; de Leon MJ
    Neurology; 2009 Feb; 72(6):513-20. PubMed ID: 19005175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.
    Honea RA; Swerdlow RH; Vidoni ED; Goodwin J; Burns JM
    Neurology; 2010 Jan; 74(2):113-20. PubMed ID: 20065246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.
    Mosconi L; Rinne JO; Tsui WH; Berti V; Li Y; Wang H; Murray J; Scheinin N; Någren K; Williams S; Glodzik L; De Santi S; Vallabhajosula S; de Leon MJ
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5949-54. PubMed ID: 20231448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism.
    Yi D; Lee Y; Byun MS; Lee JH; Ko K; Sohn BK; Choe YM; Choi HJ; Baek H; Sohn CH; Kim YK; Lee DY;
    Alzheimers Res Ther; 2018 Aug; 10(1):84. PubMed ID: 30134963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease.
    Honea RA; Swerdlow RH; Vidoni ED; Burns JM
    Neurology; 2011 Mar; 76(9):822-9. PubMed ID: 21357834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET sheds light on Alzheimer's disease genetic risk.
    Swerdlow RH
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18881-2. PubMed ID: 18025455
    [No Abstract]   [Full Text] [Related]  

  • 8. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.
    Mosconi L; De Santi S; Brys M; Tsui WH; Pirraglia E; Glodzik-Sobanska L; Rich KE; Switalski R; Mehta PD; Pratico D; Zinkowski R; Blennow K; de Leon MJ
    Biol Psychiatry; 2008 Mar; 63(6):609-18. PubMed ID: 17720148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
    Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM
    Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging.
    Reiman EM; Chen K; Langbaum JB; Lee W; Reschke C; Bandy D; Alexander GE; Caselli RJ
    Neuroimage; 2010 Jan; 49(1):169-76. PubMed ID: 19631758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease.
    Pardo JV; Lee JT;
    eNeuro; 2018; 5(1):. PubMed ID: 29497704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural brain changes in normal individuals with a maternal history of Alzheimer's.
    Berti V; Mosconi L; Glodzik L; Li Y; Murray J; De Santi S; Pupi A; Tsui W; De Leon MJ
    Neurobiol Aging; 2011 Dec; 32(12):2325.e17-26. PubMed ID: 21316814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhinal hypometabolism on FDG PET in healthy APO-E4 carriers: impact on memory function and metabolic networks.
    Didic M; Felician O; Gour N; Bernard R; Pécheux C; Mundler O; Ceccaldi M; Guedj E
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1512-21. PubMed ID: 25900275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.
    Baker LD; Cross DJ; Minoshima S; Belongia D; Watson GS; Craft S
    Arch Neurol; 2011 Jan; 68(1):51-7. PubMed ID: 20837822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional neuroanatomy of verbal memory in Alzheimer's disease: [
    Staffaroni AM; Melrose RJ; Leskin LP; Riskin-Jones H; Harwood D; Mandelkern M; Sultzer DL
    J Clin Exp Neuropsychol; 2017 Sep; 39(7):682-693. PubMed ID: 27876444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.
    Willette AA; Bendlin BB; Starks EJ; Birdsill AC; Johnson SC; Christian BT; Okonkwo OC; La Rue A; Hermann BP; Koscik RL; Jonaitis EM; Sager MA; Asthana S
    JAMA Neurol; 2015 Sep; 72(9):1013-20. PubMed ID: 26214150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes.
    Mosconi L; Berti V; Swerdlow RH; Pupi A; Duara R; de Leon M
    Hum Genomics; 2010 Feb; 4(3):170-93. PubMed ID: 20368139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.
    Hunt A; Schönknecht P; Henze M; Seidl U; Haberkorn U; Schröder J
    Psychiatry Res; 2007 Jul; 155(2):147-54. PubMed ID: 17524628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.